Top

BMC Cancer

Published in:

Open Access 01-12-2021 | Research article

Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer

Authors: Zhi Wang, Lei Tu, Minfeng Chen, Shiyu Tong

Published in: BMC Cancer | Issue 1/2021

Abstract

Background

Accumulating evidences demonstrated tumor microenvironment (TME) of bladder cancer (BLCA) may play a pivotal role in modulating tumorigenesis, progression, and alteration of biological features. Currently we aimed to establish a prognostic model based on TME-related gene expression for guiding clinical management of BLCA.

Methods

We employed ESTIMATE algorithm to evaluate TME cell infiltration in BLCA. The RNA-Seq data from The Cancer Genome Atlas (TCGA) database was used to screen out differentially expressed genes (DEGs). Underlying relationship between co-expression modules and TME was investigated via Weighted gene co-expression network analysis (WGCNA). COX regression and the least absolute shrinkage and selection operator (LASSO) analysis were applied for screening prognostic hub gene and establishing a risk predictive model. BLCA specimens and adjacent tissues from patients were obtained from patients. Bladder cancer (T24, EJ-m3) and bladder uroepithelial cell line (SVHUC1) were used for genes validation. qRT-PCR was employed to validate genes mRNA level in tissues and cell lines.

Results

365 BLCA samples and 19 adjacent normal samples were selected for identifying DEGs. 2141 DEGs were identified and used to construct co-expression network. Four modules (magenta, brown, yellow, purple) were regarded as TME regulatory modules through WGCNA and GO analysis. Furthermore, seven hub genes (ACAP1, ADAMTS9, TAP1, IFIT3, FBN1, FSTL1, COL6A2) were screened out to establish a risk predictive model via COX and LASSO regression. Survival analysis and ROC curve analysis indicated our predictive model had good performance on evaluating patients prognosis in different subgroup of BLCA. qRT-PCR result showed upregulation of ACAP1, IFIT3, TAP1 and downregulation of ADAMTS9, COL6A2, FSTL1,FBN1 in BLCA specimens and cell lines.

Conclusions

Our study firstly integrated multiple TME-related genes to set up a risk predictive model. This model could accurately predict BLCA progression and prognosis, which offers clinical implication for risk stratification, immunotherapy drug screen and therapeutic decision.

Available only for authorised users

Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, Hernández V, Linares Espinós E, Lorch A, Neuzillet Y, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol. 2021;79(1):82–104.

Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of bladder Cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–95. https://doi.org/10.1016/j.eururo.2018.09.001.CrossRefPubMed

Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, et al. Diagnosis and treatment of non-muscle invasive bladder Cancer: AUA/SUO guideline. J Urol. 2016;196(4):1021–9. https://doi.org/10.1016/j.juro.2016.06.049.CrossRefPubMed

Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, et al. Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars Cancer Biol. 2015;35 Suppl (Suppl):S199–s223.CrossRef

Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates Cancer progression. Cancer Res. 2019;79(18):4557–66. https://doi.org/10.1158/0008-5472.CAN-18-3962.CrossRefPubMedPubMedCentral

Koi M, Carethers JM. The colorectal cancer immune microenvironment and approach to immunotherapies. Future Oncol (London, England). 2017;13(18):1633–47.CrossRef

Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61–8. https://doi.org/10.1016/j.canlet.2016.01.043.CrossRefPubMed

Shiao SL, Ganesan AP, Rugo HS, Coussens LM. Immune microenvironments in solid tumors: new targets for therapy. Genes Dev. 2011;25(24):2559–72. https://doi.org/10.1101/gad.169029.111.CrossRefPubMedPubMedCentral

El-Rehim DM, El-Maqsoud NM, El-Hamid AM, El-Bab TK, Galal EM. Expression of extracellular matrix metalloproteinase inducer and fascin in urinary bladder cancer: correlation with clinicopathological characteristics. Mol Clin Oncol. 2013;1(2):297–304. https://doi.org/10.3892/mco.2013.57.CrossRefPubMedPubMedCentral

10.

Liu K, Zhao K, Wang L, Sun E. The prognostic values of tumor-infiltrating neutrophils, lymphocytes and neutrophil/lymphocyte rates in bladder urothelial cancer. Pathol Res Pract. 2018;214(8):1074–80. https://doi.org/10.1016/j.prp.2018.05.010.CrossRefPubMed

11.

Miyake M, Tatsumi Y, Gotoh D, Ohnishi S, Owari T, Iida K, et al. Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort. Int J Mol Sci. 2017;18(10). https://www.mdpi.com/1422-0067/18/10/2186.

12.

Horvath S, Dong J. Geometric interpretation of gene coexpression network analysis. PLoS Comput Biol. 2008;4(8):e1000117. https://doi.org/10.1371/journal.pcbi.1000117.CrossRefPubMedPubMedCentral

13.

Iancu OD, Colville A, Oberbeck D, Darakjian P, McWeeney SK, Hitzemann R. Cosplicing network analysis of mammalian brain RNA-Seq data utilizing WGCNA and mantel correlations. Front Genet. 2015;6:174.CrossRef

14.

Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for Cox's proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1–13. https://doi.org/10.18637/jss.v039.i05.CrossRefPubMedPubMedCentral

15.

Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337–44. https://doi.org/10.1111/j.0006-341X.2000.00337.x.CrossRef

16.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–10. https://doi.org/10.1158/0008-5472.CAN-17-0307.CrossRefPubMedPubMedCentral

17.

Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1):2612. https://doi.org/10.1038/ncomms3612.CrossRefPubMedPubMedCentral

18.

Luen S, Virassamy B, Savas P, Salgado R, Loi S. The genomic landscape of breast cancer and its interaction with host immunity. Breast (Edinburgh, Scotland). 2016;29:241–50.CrossRef

19.

Mlecnik B, Bindea G, Angell HK, Sasso MS, Obenauf AC, Fredriksen T, et al. Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients. Sci Transl Med. 2014;6(228):228ra237.CrossRef

20.

Li B, Cui Y, Diehn M, Li R. Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non-small cell lung Cancer. JAMA Oncol. 2017;3(11):1529–37. https://doi.org/10.1001/jamaoncol.2017.1609.CrossRefPubMedPubMedCentral

21.

Jia D, Li S, Li D, Xue H, Yang D, Liu Y. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Aging. 2018;10(4):592–605. https://doi.org/10.18632/aging.101415.CrossRefPubMedPubMedCentral

22.

Deng Z, Wang J, Xu B, Jin Z, Wu G, Zeng J, et al. Mining TCGA database for tumor microenvironment-related genes of prognostic value in hepatocellular carcinoma. Biomed Res Int. 2019;2019:2408348.PubMedPubMedCentral

23.

Cao J, Yang X, Li J, Wu H, Li P, Yao Z, et al. Screening and identifying immune-related cells and genes in the tumor microenvironment of bladder urothelial carcinoma: based on TCGA database and bioinformatics. Front Oncol. 2019;9:1533.CrossRef

24.

Zhang Z, Chen D, Li Z, Liu Z, Yan L, Xu Z. Bioinformatics analysis to screen the key prognostic genes in tumor microenvironment of bladder Cancer. Biomed Res Int. 2020;2020:6034670.PubMedPubMedCentral

25.

Bai F, Jin Y, Zhang P, Chen H, Fu Y, Zhang M, et al. Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment. Aging. 2019;11(21):9328–47. https://doi.org/10.18632/aging.102373.CrossRefPubMedPubMedCentral

26.

Yan H, Qu J, Cao W, Liu Y, Zheng G, Zhang E, et al. Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis. Cancer Immunol Immunother. 2019;68(12):1971–8. https://doi.org/10.1007/s00262-019-02408-7.CrossRefPubMed

27.

Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder Cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82–104. https://doi.org/10.1016/j.eururo.2020.03.055.CrossRefPubMed

28.

Eble JA, Niland S. The extracellular matrix in tumor progression and metastasis. Clin Exp metastasis. 2019;36(3):171–98. https://doi.org/10.1007/s10585-019-09966-1.CrossRefPubMed

29.

Rao Q, Chen Y, Yeh CR, Ding J, Li L, Chang C, et al. Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals. Oncotarget. 2016;7(7):7842–55. https://doi.org/10.18632/oncotarget.5467.CrossRefPubMed

30.

Chen MF, Lin PY, Wu CF, Chen WC, Wu CT. IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer. PLoS One. 2013;8(4):e61901. https://doi.org/10.1371/journal.pone.0061901.CrossRefPubMedPubMedCentral

31.

Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics. 2008;9(1):559. https://doi.org/10.1186/1471-2105-9-559.CrossRefPubMedPubMedCentral

32.

Yang Y, Han L, Yuan Y, Li J, Hei N, Liang H. Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types. Nat Commun. 2014;5(1):3231. https://doi.org/10.1038/ncomms4231.CrossRefPubMedPubMedCentral

33.

Goeman JJ. L1 penalized estimation in the cox proportional hazards model. Biometrical J. 2010;52(1):70–84.

34.

Yu A, Mansure JJ, Solanki S, Siemens DR, Koti M, Dias ABT, et al. Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy. PLoS One. 2018;13(10):e0205746. https://doi.org/10.1371/journal.pone.0205746.CrossRefPubMedPubMedCentral

35.

Eruslanov E, Neuberger M, Daurkin I, Perrin GQ, Algood C, Dahm P, et al. Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer. 2012;130(5):1109–19. https://doi.org/10.1002/ijc.26123.CrossRefPubMed

36.

Xue Y, Tong L, LiuAnwei Liu F, Liu A, Zeng S, Xiong Q, et al. Tumor-infiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer. Oncol Rep. 2019;42(2):581–94.PubMedPubMedCentral

37.

Pan S, Zhan Y, Chen X, Wu B, Liu B. Bladder Cancer exhibiting high immune infiltration shows the lowest response rate to immune checkpoint inhibitors. Front Oncol. 2019;9:1101. https://doi.org/10.3389/fonc.2019.01101.CrossRefPubMedPubMedCentral

38.

Gaucherand L, Falk BA, Evanko SP, Workman G, Chan CK, Wight TN. Crosstalk between T lymphocytes and lung fibroblasts: generation of a Hyaluronan-enriched extracellular matrix adhesive for monocytes. J Cell Biochem. 2017;118(8):2118–30. https://doi.org/10.1002/jcb.25842.CrossRefPubMedPubMedCentral

39.

Wang H, Wu S, Huang S, Yin S, Zou G, Huang K, et al. Follistatin-like protein 1 contributes to dendritic cell and T-lymphocyte activation in nasopharyngeal carcinoma patients by altering nuclear factor κb and Jun N-terminal kinase expression. Cell Biochem Funct. 2016;34(8):554–62. https://doi.org/10.1002/cbf.3227.CrossRefPubMedPubMedCentral

40.

Scheurer MJJ, Brands RC, El-Mesery M, Hartmann S, Müller-Richter UDA, Kübler AC, et al. The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy. Int J Mol Sci. 2019;20(6). https://www.mdpi.com/1422-0067/20/6/1306.

41.

Hu L, Wang Y, Chen Z, Fu L, Wang S, Zhang X, et al. Hsp90 inhibitor SNX-2112 enhances TRAIL-induced apoptosis of human cervical Cancer cells via the ROS-mediated JNK-p53-autophagy-DR5 pathway. Oxidative Med Cell Longev. 2019;2019:9675450.

42.

Xi C, Wang L, Yu J, Ye H, Cao L, Gong Z. Inhibition of cyclin-dependent kinases by AT7519 is effective to overcome chemoresistance in colon and cervical cancer. Biochem Biophys Res Commun. 2019;513(3):589–93. https://doi.org/10.1016/j.bbrc.2019.04.014.CrossRefPubMed

Title: Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer
Authors: Zhi Wang
Lei Tu
Minfeng Chen
Shiyu Tong
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-021-08447-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Skin cancers in people with albinism in Togo in 2019: results of two rounds of national mobile skin care clinics

Predicting breast cancer drug response using a multiple-layer cell line drug response network model

The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis

The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009–2018

Associations between multimorbidity and depression among breast cancer survivors within the UK Biobank cohort: a cross-sectional study

Immune checkpoint inhibitors-related myocarditis in patients with cancer: an analysis of international spontaneous reporting systems

Keynote webinar | Spotlight on antibody–drug conjugates in cancer